Nova Eye Medical Limited (EYE) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nova Eye Medical Ltd.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.246 -- 00:00:04.590 Good morning, everyone. Thank you again for joining us today. 00:00:04.590 -- 00:00:08.154 My name is Mark Flynn from the Investor Relations at Novi Medical Limited. 00:00:08.154 -- 00:00:12.099 Today's session is an investor briefing, but just a brief reminder, we will include some 00:00:12.099 -- 00:00:15.744 forward-looking statements. Actual outcomes may differ due to risks and uncertainties, 00:00:15.744 -- 00:00:18.807 but please refer to the disclaimer in the presentation. 00:00:18.807 -- 00:00:22.172 Format straightforward as usual. Tom will first walk through a short presentation. 00:00:22.172 -- 00:00:25.428 After that, I'll ask a number of questions received from investors. 00:00:25.428 -- 00:00:28.972 If you'd like to ask a question today, please use the Q&A function in Zoom, and I'll 00:00:28.972 -- 00:00:31.175 do my best to get through as many as possible. 00:00:31.175 -- 00:00:35.117 With that, I'll hand over to Managing Director, Tom Sperling. 00:00:35.260 -- 00:00:38.283 Thanks, Mark, and thanks, everyone, for joining us today. 00:00:38.283 -- 00:00:44.631 We've got a good turnout, and for those long-time listeners, long-term listeners, 00:00:44.631 -- 00:00:50.658 some repeating of the message, but I find that that will help 00:00:50.658 -- 00:00:55.241 get more people understanding our story. If you hear it more than once, and for those 00:00:55.241 -- 00:01:00.486 new ones, so thank you, bear with me. Glaucoma is about the buildup of pressure. 00:01:00.486 -- 00:01:05.490 A failure of plumbing, building up of pressure can lead to 00:01:05.490 -- 00:01:08.072 crushing of the optic nerve and blindness. 00:01:08.072 -- 00:01:12.116 It's a big market. Next slide, Mark. 00:01:12.116 -- 00:01:15.458 We described our ...